Brief: Fuji Pharma Co Says To Form Capital Tie-Up With Taiwan's Lotus Pharmaceutical
20/03/2019 01:15
March 20 (Reuters) - Fuji Pharma Co Ltd 4554.T :
* SAYS TO FORM CAPITAL TIE-UP WITH TAIWAN'S LOTUS
PHARMACEUTICAL
Source text for Eikon: ID:nTSOT78498
Further company coverage: 4554.T
(Reporting by Takashi Umekawa)
((Takashi.Umekawa@thomsonreuters.com;))
Recent news on Lotus Pharmaceutical
See all newsMedia: PTT is said to consider options for Taiwan-listed Lotus Pharma - Bloomberg News
Brief: enz Therapeutics Submits NDA for LNZ100 (Vizz) in South Korea to Treat Presbyopia
Brief: Lotus Pharmaceutical Says Unit Has Closed Deal In Vietnam
Brief: Fuji Pharma: Marketing Approval For Generic Lenalidomide, The First Collaboration Product With Taiwan's Lotus
Brief: Amarin And Lotus Pharmaceuticals Announce Exclusive Partnership In Southeast Asia And South Korea